Affinage

NIF3L1

NIF3-like protein 1 · UniProt Q9GZT8

Length
377 aa
Mass
42.0 kDa
Annotated
2026-04-29
8 papers in source corpus 4 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

NIF3L1 is a conserved cytoplasmic protein that functions as a transcriptional repressor and promotes neural differentiation. Under basal conditions NIF3L1 resides in the cytoplasm, where it homodimerizes and forms complexes with NIF3L1 BP1, WBSCR14, and 14-3-3 proteins in a phosphorylation-dependent manner (PMID:12951069, PMID:15163635). During retinoic acid-induced neural differentiation, NIF3L1 translocates to the nucleus—a process enhanced by its partner Trip15/CSN2—where it represses transcription, down-regulates Oct-3/4, and induces the proneural factor Mash-1, thereby driving neuronal commitment of P19 embryonal carcinoma cells (PMID:12522100).

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 2000 Medium

    The subcellular localization of NIF3L1 was unknown; GFP-fusion imaging established that the protein resides in the cytoplasm under basal conditions, providing the first spatial framework for interpreting its function.

    Evidence GFP-fusion fluorescence microscopy in mammalian cells

    PMID:11124544

    Open questions at the time
    • Single overexpression-based method; endogenous localization not confirmed by antibody staining
    • No functional consequence of cytoplasmic localization explored
  2. 2003 High

    NIF3L1 lacked known molecular activities; identification of Trip15/CSN2 as a binding partner and demonstration that NIF3L1 acts as a transcriptional repressor that synergizes with Trip15/CSN2 established its role in gene silencing and retinoic acid-primed neural differentiation, including Oct-3/4 down-regulation and Mash-1 induction.

    Evidence Yeast two-hybrid, pull-down, co-immunoprecipitation, luciferase reporter assays, gain- and loss-of-function in P19 cells with subcellular fractionation showing nuclear translocation during differentiation

    PMID:12522100

    Open questions at the time
    • Direct DNA-binding or chromatin target sites of NIF3L1 not identified
    • Mechanism by which NIF3L1 represses transcription (direct vs. indirect) undefined
    • In vivo relevance (knockout animal) not tested
  3. 2003 Medium

    Whether NIF3L1 functions as a monomer or oligomer was unresolved; discovery of homodimerization and interaction with the novel leucine-zipper protein NIF3L1 BP1 in the cytoplasm revealed that NIF3L1 participates in cytoplasmic protein complexes beyond its nuclear repressor role.

    Evidence Yeast two-hybrid screen of HeLa cDNA library, mammalian two-hybrid, deletion mapping, cotransfection/colocalization in LNCaP cells

    PMID:12951069

    Open questions at the time
    • No reciprocal endogenous co-IP or in vitro reconstitution of the dimer or NIF3L1 BP1 complex
    • Functional significance of homodimerization and NIF3L1 BP1 interaction not determined
  4. 2004 Medium

    The broader signaling context of NIF3L1 was unclear; identification of a phosphorylation-dependent ternary complex with WBSCR14 and 14-3-3 isoforms connected NIF3L1 to phospho-regulated cytoplasmic signaling.

    Evidence Co-immunoprecipitation and phosphatase treatment in mammalian cells, yeast two-hybrid

    PMID:15163635

    Open questions at the time
    • Which kinase phosphorylates WBSCR14 or NIF3L1 to drive complex assembly is unknown
    • Direct versus bridged interaction between NIF3L1 and 14-3-3 not resolved
    • Physiological function of this ternary complex not defined

Open questions

Synthesis pass · forward-looking unresolved questions
  • The enzymatic or structural basis of NIF3L1's repressor activity, its direct genomic targets, and its in vivo requirement in neural development remain uncharacterized.
  • No ChIP or genome-wide target identification performed
  • No knockout or conditional loss-of-function animal model reported
  • Crystal structure or biochemical activity of the conserved NIF3 domain not determined in mammalian systems

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 1
Localization
GO:0005829 cytosol 3 GO:0005634 nucleus 2
Pathway
R-HSA-1266738 Developmental Biology 1 R-HSA-74160 Gene expression (Transcription) 1

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2003 Nif3l1 interacts with Trip15/CSN2 (a transcriptional corepressor/COP9 signalosome component), confirmed by yeast two-hybrid, pull-down assay, and coimmunoprecipitation. Nif3l1 acts as a transcriptional repressor and synergizes with Trip15/CSN2 in transcriptional repression. Enforced Nif3l1 expression enhances retinoic acid-primed neural differentiation of P19 cells, accompanied by down-regulation of Oct-3/4 and induction of Mash-1. Yeast two-hybrid, pull-down assay, epitope-tagged coimmunoprecipitation, luciferase reporter assay, sense/antisense overexpression in P19 cells The Journal of biological chemistry High 12522100
2003 Nif3l1 is mainly detected in the cytoplasm under basal conditions, but translocates into the nucleus during retinoic acid-primed neural differentiation of P19 cells; this nuclear translocation is enhanced by enforced expression of Trip15/CSN2. Subcellular fractionation/immunolocalization, overexpression of Trip15/CSN2 in P19 cells The Journal of biological chemistry Medium 12522100
2003 Human NIF3L1 interacts with itself (homodimerizes) and with a novel binding partner NIF3L1 BP1 (a 23.67 kDa protein bearing a putative leucine zipper domain). A C-terminal region of 100 amino acids of NIF3L1 BP1 is sufficient for interaction with NIF3L1. Both interactions occur in the cytoplasm of human LNCaP cells. Yeast two-hybrid screening of HeLa cDNA library, mammalian two-hybrid system, deletion analysis, cotransfection/colocalization in LNCaP cells Biochemical and biophysical research communications Medium 12951069
2004 NIF3L1 forms a single polypeptide complex with WBSCR14 and four 14-3-3 isotypes in mammalian cells. This complex was identified by co-immunoprecipitation, and phosphatase treatment abrogates the WBSCR14–14-3-3 association, indicating phosphorylation-dependent interaction. Yeast two-hybrid, coimmunoprecipitation, phosphatase treatment Human molecular genetics Medium 15163635
2000 A GFP fusion protein of human NIF3L1 localizes to the cytoplasm, establishing the basal subcellular localization of the protein. GFP fusion protein fluorescence microscopy Cytogenetics and cell genetics Medium 11124544

Source papers

Stage 0 corpus · 8 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2004 The subcellular localization of the ChoRE-binding protein, encoded by the Williams-Beuren syndrome critical region gene 14, is regulated by 14-3-3. Human molecular genetics 62 15163635
2001 Cloning and characterization of three novel genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the juvenile amyotrophic lateral sclerosis (ALS2) critical region at chromosome 2q33-q34: candidate genes for ALS2. Genomics 41 11161814
2003 The role of transcriptional corepressor Nif3l1 in early stage of neural differentiation via cooperation with Trip15/CSN2. The Journal of biological chemistry 27 12522100
2003 Identification and characterization of NIF3L1 BP1, a novel cytoplasmic interaction partner of the NIF3L1 protein. Biochemical and biophysical research communications 17 12951069
2000 Isolation and characterization of a novel human gene, NIF3L1, and its mouse ortholog, Nif3l1, highly conserved from bacteria to mammals. Cytogenetics and cell genetics 15 11124544
2019 Relationship between osteoporosis and osteoarthritis based on DNA methylation. International journal of clinical and experimental pathology 12 31934183
2023 The Ubiquitin-Proteasome System Participates in Sperm Surface Subproteome Remodeling during Boar Sperm Capacitation. Biomolecules 10 37371576
2024 Serum biomarkers in patients with drug-resistant epilepsy: a proteomics-based analysis. Frontiers in neurology 6 38585359